Logo image of VEEV

VEEVA SYSTEMS INC-CLASS A (VEEV) Stock Fundamental Analysis

NYSE:VEEV - New York Stock Exchange, Inc. - US9224751084 - Common Stock - Currency: USD

225.79  -2.95 (-1.29%)

After market: 225.79 0 (0%)

Fundamental Rating

7

Overall VEEV gets a fundamental rating of 7 out of 10. We evaluated VEEV against 39 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making VEEV a very profitable company, without any liquidiy or solvency issues. VEEV is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make VEEV a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

VEEV had positive earnings in the past year.
In the past year VEEV had a positive cash flow from operations.
VEEV had positive earnings in each of the past 5 years.
VEEV had a positive operating cash flow in each of the past 5 years.
VEEV Yearly Net Income VS EBIT VS OCF VS FCFVEEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

With an excellent Return On Assets value of 10.32%, VEEV belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
VEEV has a better Return On Equity (12.10%) than 94.59% of its industry peers.
VEEV has a Return On Invested Capital of 9.08%. This is amongst the best in the industry. VEEV outperforms 97.30% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VEEV is above the industry average of 6.44%.
Industry RankSector Rank
ROA 10.32%
ROE 12.1%
ROIC 9.08%
ROA(3y)10.08%
ROA(5y)11.19%
ROE(3y)13.04%
ROE(5y)14.79%
ROIC(3y)10.05%
ROIC(5y)11.22%
VEEV Yearly ROA, ROE, ROICVEEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 25.07%, VEEV belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
VEEV's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 24.22%, VEEV belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
In the last couple of years the Operating Margin of VEEV has declined.
The Gross Margin of VEEV (73.93%) is better than 81.08% of its industry peers.
VEEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.22%
PM (TTM) 25.07%
GM 73.93%
OM growth 3Y-11.02%
OM growth 5Y-6.82%
PM growth 3Y-5%
PM growth 5Y-3.55%
GM growth 3Y-0.34%
GM growth 5Y-0.06%
VEEV Yearly Profit, Operating, Gross MarginsVEEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

VEEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VEEV has been increased compared to 1 year ago.
The number of shares outstanding for VEEV has been increased compared to 5 years ago.
VEEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VEEV Yearly Shares OutstandingVEEV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VEEV Yearly Total Debt VS Total AssetsVEEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

VEEV has an Altman-Z score of 25.72. This indicates that VEEV is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 25.72, VEEV belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
VEEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 25.72
ROIC/WACC0.89
WACC10.18%
VEEV Yearly LT Debt VS Equity VS FCFVEEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

VEEV has a Current Ratio of 6.36. This indicates that VEEV is financially healthy and has no problem in meeting its short term obligations.
VEEV has a better Current ratio (6.36) than 97.30% of its industry peers.
VEEV has a Quick Ratio of 6.36. This indicates that VEEV is financially healthy and has no problem in meeting its short term obligations.
VEEV's Quick ratio of 6.36 is amongst the best of the industry. VEEV outperforms 97.30% of its industry peers.
Industry RankSector Rank
Current Ratio 6.36
Quick Ratio 6.36
VEEV Yearly Current Assets VS Current LiabilitesVEEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

8

3. Growth

3.1 Past

VEEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.57%, which is quite impressive.
The Earnings Per Share has been growing by 24.47% on average over the past years. This is a very strong growth
VEEV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.67%.
Measured over the past years, VEEV shows a very strong growth in Revenue. The Revenue has been growing by 22.35% on average per year.
EPS 1Y (TTM)35.57%
EPS 3Y18.08%
EPS 5Y24.47%
EPS Q2Q%30.6%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y17.28%
Revenue growth 5Y22.35%
Sales Q2Q%13.41%

3.2 Future

VEEV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.21% yearly.
Based on estimates for the next years, VEEV will show a quite strong growth in Revenue. The Revenue will grow by 13.25% on average per year.
EPS Next Y34.83%
EPS Next 2Y20.67%
EPS Next 3Y17.47%
EPS Next 5Y16.21%
Revenue Next Year16.12%
Revenue Next 2Y14.14%
Revenue Next 3Y13.68%
Revenue Next 5Y13.25%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VEEV Yearly Revenue VS EstimatesVEEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
VEEV Yearly EPS VS EstimatesVEEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 36.13, which means the current valuation is very expensive for VEEV.
83.78% of the companies in the same industry are more expensive than VEEV, based on the Price/Earnings ratio.
VEEV is valuated rather expensively when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 32.04, the valuation of VEEV can be described as expensive.
Based on the Price/Forward Earnings ratio, VEEV is valued cheaply inside the industry as 81.08% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.68. VEEV is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 36.13
Fwd PE 32.04
VEEV Price Earnings VS Forward Price EarningsVEEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VEEV is valued a bit cheaper than the industry average as 70.27% of the companies are valued more expensively.
VEEV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. VEEV is cheaper than 67.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.75
EV/EBITDA 41.17
VEEV Per share dataVEEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of VEEV may justify a higher PE ratio.
VEEV's earnings are expected to grow with 17.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.04
PEG (5Y)1.48
EPS Next 2Y20.67%
EPS Next 3Y17.47%

More info and screens

0

5. Dividend

5.1 Amount

VEEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VEEVA SYSTEMS INC-CLASS A

NYSE:VEEV (2/21/2025, 8:04:00 PM)

After market: 225.79 0 (0%)

225.79

-2.95 (-1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners83.6%
Inst Owner Change6.3%
Ins Owners8.85%
Ins Owner Change0.03%
Market Cap36.66B
Analysts77.37
Price Target269.98 (19.57%)
Short Float %2.51%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.06%
Min EPS beat(2)3.51%
Max EPS beat(2)8.61%
EPS beat(4)4
Avg EPS beat(4)4.86%
Min EPS beat(4)3.17%
Max EPS beat(4)8.61%
EPS beat(8)8
Avg EPS beat(8)5.83%
EPS beat(12)11
Avg EPS beat(12)4.64%
EPS beat(16)15
Avg EPS beat(16)6.1%
Revenue beat(2)0
Avg Revenue beat(2)-0.62%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-0.6%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-0.72%
Revenue beat(12)1
Avg Revenue beat(12)-0.67%
Revenue beat(16)4
Avg Revenue beat(16)-0.19%
PT rev (1m)-1.26%
PT rev (3m)12.92%
EPS NQ rev (1m)2.69%
EPS NQ rev (3m)-2%
EPS NY rev (1m)0.08%
EPS NY rev (3m)3.73%
Revenue NQ rev (1m)0.6%
Revenue NQ rev (3m)-2.17%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 36.13
Fwd PE 32.04
P/S 13.8
P/FCF 34.75
P/OCF 34
P/B 6.66
P/tB 7.31
EV/EBITDA 41.17
EPS(TTM)6.25
EY2.77%
EPS(NY)7.05
Fwd EY3.12%
FCF(TTM)6.5
FCFY2.88%
OCF(TTM)6.64
OCFY2.94%
SpS16.36
BVpS33.89
TBVpS30.88
PEG (NY)1.04
PEG (5Y)1.48
Profitability
Industry RankSector Rank
ROA 10.32%
ROE 12.1%
ROCE 11.5%
ROIC 9.08%
ROICexc 95.37%
ROICexgc 1142.97%
OM 24.22%
PM (TTM) 25.07%
GM 73.93%
FCFM 39.71%
ROA(3y)10.08%
ROA(5y)11.19%
ROE(3y)13.04%
ROE(5y)14.79%
ROIC(3y)10.05%
ROIC(5y)11.22%
ROICexc(3y)55.65%
ROICexc(5y)49.48%
ROICexgc(3y)356.57%
ROICexgc(5y)339.82%
ROCE(3y)12.72%
ROCE(5y)14.2%
ROICexcg growth 3Y-13.2%
ROICexcg growth 5Y-16.56%
ROICexc growth 3Y2.45%
ROICexc growth 5Y-14.96%
OM growth 3Y-11.02%
OM growth 5Y-6.82%
PM growth 3Y-5%
PM growth 5Y-3.55%
GM growth 3Y-0.34%
GM growth 5Y-0.06%
F-Score6
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 61.8%
Cap/Sales 0.89%
Interest Coverage 250
Cash Conversion 158.26%
Profit Quality 158.39%
Current Ratio 6.36
Quick Ratio 6.36
Altman-Z 25.72
F-Score6
WACC10.18%
ROIC/WACC0.89
Cap/Depr(3y)59.5%
Cap/Depr(5y)45.92%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.7%
Profit Quality(3y)167.06%
Profit Quality(5y)157.56%
High Growth Momentum
Growth
EPS 1Y (TTM)35.57%
EPS 3Y18.08%
EPS 5Y24.47%
EPS Q2Q%30.6%
EPS Next Y34.83%
EPS Next 2Y20.67%
EPS Next 3Y17.47%
EPS Next 5Y16.21%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y17.28%
Revenue growth 5Y22.35%
Sales Q2Q%13.41%
Revenue Next Year16.12%
Revenue Next 2Y14.14%
Revenue Next 3Y13.68%
Revenue Next 5Y13.25%
EBIT growth 1Y59.67%
EBIT growth 3Y4.35%
EBIT growth 5Y14.01%
EBIT Next Year37.82%
EBIT Next 3Y19.8%
EBIT Next 5Y19.36%
FCF growth 1Y39.2%
FCF growth 3Y17.73%
FCF growth 5Y24.08%
OCF growth 1Y39.82%
OCF growth 3Y18.25%
OCF growth 5Y24.01%